Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments

Figure 1

Role of rebiopsy in NSCLC treatment selection. Rebiopsy will renew tumor characteristics and give opportunity to act on changes of tumor behavior. Rebiopsy can confirm old existing targets when current therapies are allowed, or it can find new targets that need to be treated with new drug molecules in clinical trials. Thus changes in treatment facilitate better tumor control.